Pfizer CEO Albert Bourla joins CNBC's 'Special Report' as President-elect Donald Trump is inaugurated as the 47th U.S.

With morale at a low point, biotech and pharma CEOs are cautiously optimistic about the incoming Trump administration.

We recently published an article titled Jim Cramer Discussed These 21 Stocks As Bond Yields Soared. In this article, we are ...

While presenting at the JP Morgan Healthcare Conference, Pfizer Inc. (NYSE:PFE) Albert Bourla, Chairman and CEO, said, “I ...

At the JPM conference, Pfizer CEO Albert Bourla projected optimism, saying the market was overlooking the pharma company's ...

Topics up for discussion range from carbon pricing and the economics of nature to changing weather patterns and upcoming ...

CEO Albert Bourla said the company’s dispute with activist firm Starboard Value isn’t “an aggressive situation,” months after the ...

Of the 24 analysts covering Pfizer, 11 have a “Strong Buy” rating while 12 rate it as a “Hold” or some equivalent. One ...

Jim Cramer on Pfizer Inc. (PFE) CEO Albert Bourla: ‘President-elect Trump Felt That Bourla Was A Hero During COVID’ Ramish Cheema Tue, Jan 14, 2025, 12:20 PM 7 min read ...

It’s not just the tech billionaires descending on Washington. Plenty of chief executives from other industries are also ...

Pfizer Chairman and CEO Albert Bourla did not mince his words at the 43rd annual J.P. Morgan Healthcare Conference in San Francisco on Monday regarding the controversial positions that Robert F.